These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8436503)

  • 1. [Encephalocraniocutaneous lipomatosis. A non-hereditary mosaic phenotype].
    Happle R; Steijlen PM
    Hautarzt; 1993 Jan; 44(1):19-22. PubMed ID: 8436503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalp lipomas and cerebral malformations--report of a case and review of the literature.
    Fryer AE
    Clin Dysmorphol; 1992 Apr; 1(2):99-102. PubMed ID: 1345519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalocraniocutaneous lipomatosis, Proteus syndrome, and somatic mosaicism.
    Rizzo R; Pavone L; Micali G; Nigro F; Cohen MM
    Am J Med Genet; 1993 Oct; 47(5):653-5. PubMed ID: 8266992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalocraniocutaneous lipomatosis.
    Moog U
    J Med Genet; 2009 Nov; 46(11):721-9. PubMed ID: 19574261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encephalocraniocutaneous lipomatosis and linear naevus sebaceus].
    Schlack HG; Skopnik H
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):235-7. PubMed ID: 4000139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalocraniocutaneous lipomatosis and mixed odontogenic tumors.
    Savage MG; Heldt L; Dann JJ; Bump RL
    J Oral Maxillofac Surg; 1985 Aug; 43(8):617-20. PubMed ID: 3859613
    [No Abstract]   [Full Text] [Related]  

  • 7. Encephalocraniocutaneous Lipomatosis Without Ocular Malformations.
    Radić Nišević J; Prpić I; Antulov R; Sasso A; Holjar Erlić I
    Pediatr Neurol; 2016 Jul; 60():71-4. PubMed ID: 27131628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral cutaneous and visceral involvement.
    Rubegni P; Risulo M; Sbano P; Buonocore G; Perrone S; Fimiani M
    Clin Exp Dermatol; 2003 Jul; 28(4):387-90. PubMed ID: 12823300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalocraniocutaneous lipomatosis: a case with unilateral odontomas and review of the literature.
    Hauber K; Warmuth-Metz M; Rose C; Bröcker EB; Hamm H
    Eur J Pediatr; 2003 Sep; 162(9):589-93. PubMed ID: 12884033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encephalocraniocutaneous lipomatosis.
    Fishman MA; Chang CS; Miller JE
    Pediatrics; 1978 Apr; 61(4):580-2. PubMed ID: 662483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalocraniocutaneous lipomatosis.
    Fishman MA
    J Child Neurol; 1987 Jul; 2(3):186-93. PubMed ID: 3611632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
    Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
    J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial multiple lipomatosis.
    Mohar N
    Acta Derm Venereol; 1980; 60(6):509-13. PubMed ID: 6162336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome.
    Brown KE; Goldstein SM; Douglas RS; Katowitz JA
    J AAPOS; 2003 Apr; 7(2):148-9. PubMed ID: 12736631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant Ocular Lipodermoid Cyst in Encephalocraniocutaneous Lipomatosis: Surgical Treatment and Genetic Analysis.
    Córdoba A; Graue-Hernández EO; Navas A; Chacon-Camacho OF; Zenteno JC; Ramirez-Miranda A; Bermudez-Magner JA; Ordaz-Robles T; Pérez-Solórzano S; Olivo-Payne A
    Am J Case Rep; 2019 Oct; 20():1566-1571. PubMed ID: 31649234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalocraniocutaneous lipomatosis: a new neurocutaneous syndrome.
    Sanchez NP; Rhodes AR; Mandell F; Mihm MC
    Br J Dermatol; 1981 Jan; 104(1):89-96. PubMed ID: 6893936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular and systemic manifestations of encephalocraniocutaneous lipomatosis.
    Kodsi SR; Bloom KE; Egbert JE; Holland EJ; Cameron JD
    Am J Ophthalmol; 1994 Jul; 118(1):77-82. PubMed ID: 8023879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encephalocraniocutaneous lipomatosis and the Proteus syndrome: distinct entities with overlapping manifestations.
    McCall S; Ramzy MI; Curé JK; Pai GS
    Am J Med Genet; 1992 Jul; 43(4):662-8. PubMed ID: 1621755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
    Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
    Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations in Delleman syndrome (Oculocerebrocutaneous syndrome, OCC-syndrome) and encephalocraniocutaneous lipomatosis (ECCL). Report of three cases.
    Narbay G; Meire F; Verloes A; Casteels I; Devos E
    Bull Soc Belge Ophtalmol; 1996; 261():65-70. PubMed ID: 9009364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.